The EU Pharmacovigilance Risk Assesment Committee (PRAC) convened on 10-13 June 2013. Among the topics discussed at the meeting were:
- PRAC recommends restricting use of codeine when used for pain relief in children
- PRAC recommendation on diclofenac
- PRAC recommends suspension of hydroxyethyl-starch-containing solution for infusion
- PRAC recommendation on flupirtine-containing medicines
- New referral procedure for Numeta G13%E and G16%E
Please see the PRAC's monthly report: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 June 2013